Trials / Conditions / Androgen Deficiency

Androgen Deficiency

13 registered clinical trials studyying Androgen Deficiency — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	PREDICTORS OF TESTOSTERONE DECLINE IN MIDDLE-AGED MEN NCT07476222	Andijan State Medical Institute	—
Unknown	Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance i NCT05773183	Royal College of Surgeons, Ireland	—
Completed	Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial) NCT04895306	Brigham and Women's Hospital	Phase 2
Unknown	Cross-sectional Study of 1200 Recreational Athletes With Former or Current Use of Androgenic Anabolic Steroids NCT05178537	Jan Frystyk	—
Withdrawn	Pioglitazone and Insulin Resistance in ADT NCT05098327	State University of New York at Buffalo	Phase 3
Recruiting	Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury NCT04460872	North Florida Foundation for Research and Education	Phase 2
Withdrawn	In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity NCT04368897	Applied Biology, Inc.	—
Completed	The Effects of Androgen Replacement Therapy on Tear Osmolarity and Ocular Surface Parameters in Androgen Defic NCT07168265	Neon Hospital	N/A
Unknown	Physical Exercise for Men With Andropause NCT03150225	Laboratório de Pesquisa em Lazer e Atividade Física	N/A
Completed	T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insul NCT01686828	University of Washington	Phase 1 / Phase 2
Completed	Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes NCT01190904	Icahn School of Medicine at Mount Sinai	—
Completed	Registry of Hypogonadism in Men NCT00858650	Carelon Research	—
Completed	Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Ad NCT00540553	GlaxoSmithKline	Phase 1